Hazel O’Sullivan

542 total citations
10 papers, 288 citations indexed

About

Hazel O’Sullivan is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hazel O’Sullivan has authored 10 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Hazel O’Sullivan's work include Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and Advanced Breast Cancer Therapies (1 paper). Hazel O’Sullivan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and Advanced Breast Cancer Therapies (1 paper). Hazel O’Sullivan collaborates with scholars based in Ireland, New Zealand and United Kingdom. Hazel O’Sullivan's co-authors include Fergal C. Kelleher, Elizabeth Smyth, Ray McDermott, Séamus O’Reilly, Dearbhaile Catherine Collins, Derek G. Power, Richard Bambury, Carmel G. Cronin, Michael Conroy and Delwood C. Collins and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Hazel O’Sullivan

9 papers receiving 284 citations

Peers

Hazel O’Sullivan

MB

ONCOL

CR

PRM

IMMUN

Hiroki Kasama Japan

Karen J. Dunbar United States

Rosanna Pellicani Italy

Xian-Zi Yang China

Yingke Zhou China

Shaoqiang Cheng China

Hakki Ogün Sercan Türkiye

Natsumi Kawasaki Japan

Junyu Tan China

Adrià Bernat‐Peguera Spain

Hiroki Kasama Japan

Hazel O’Sullivan

192 ×1.0

MB

76 ×0.9

ONCOL

96 ×1.4

CR

42 ×0.9

PRM

32 ×0.8

IMMUN

Citations per year, relative to Hazel O’Sullivan Hazel O’Sullivan (= 1×) peers Hiroki Kasama

Countries citing papers authored by Hazel O’Sullivan

Since Specialization

Citations

This map shows the geographic impact of Hazel O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel O’Sullivan more than expected).

Fields of papers citing papers by Hazel O’Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel O’Sullivan. The network helps show where Hazel O’Sullivan may publish in the future.

Co-authorship network of co-authors of Hazel O’Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel O’Sullivan. A scholar is included among the top collaborators of Hazel O’Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel O’Sullivan. Hazel O’Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Conroy, Michael, Hazel O’Sullivan, Delwood C. Collins, et al.. (2024). Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors. PubMed. 2(1). 31–31. 9 indexed citations

2.

Grieco, Charlotte, Hazel O’Sullivan, & Wanyuan Cui. (2022). A case of multiple recurrent immune-related adverse events (irAEs) with sequential sotorasib after chemoimmunotherapy for KRAS G12C-mutant non-small cell lung cancer (NSCLC). Lung Cancer. 165. S72–S73.

3.

O’Sullivan, Hazel, et al.. (2020). Integrated multimodality and multi-disciplinary team approach to pre-sacral lesions. Clinical Imaging. 67. 255–263. 4 indexed citations

4.

O’Sullivan, Hazel, Dearbhaile Catherine Collins, Deirdre O’Mahony, et al.. (2019). End-of-life care and immune checkpoint inhibitors.. Journal of Clinical Oncology. 37(15_suppl). 11531–11531. 2 indexed citations

5.

O’Sullivan, Hazel, Dearbhaile Catherine Collins, & Séamus O’Reilly. (2019). Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. New England Journal of Medicine. 380(10). 985–988. 52 indexed citations

6.

Kelleher, Fergal C. & Hazel O’Sullivan. (2017). Monocytes, Macrophages, and Osteoclasts in Osteosarcoma. Journal of Adolescent and Young Adult Oncology. 6(3). 396–405. 57 indexed citations

7.

Kelleher, Fergal C., et al.. (2017). BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis. World Journal of Gastroenterology. 23(17). 3022–3022. 1 indexed citations

8.

Kelleher, Fergal C. & Hazel O’Sullivan. (2016). FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways. Oncotarget. 7(27). 42792–42804. 50 indexed citations

9.

Kelleher, Fergal C., et al.. (2013). Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis. 34(10). 2198–2205. 106 indexed citations

10.

Kelleher, Fergal C. & Hazel O’Sullivan. (2013). Oxford and the Savannah: Can the Hippo Provide an Explanation for Peto's Paradox?. Clinical Cancer Research. 20(3). 557–564. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact